Introduction and Objectives: Stone formers often have a chronic exposure to significant quantities of ionising radiation from radiological investigations and interventions. Predicting radiation exposure would allow the clinician to quantify expected cumulative radiation and find strategies to minimise exposure. We evaluated radiation exposure during ureteroscopy and laser lithotripsy (URS + LL) for a single stone episode and correlated the results to stone characteristics. Method: Data was collected retrospectively for all patients undergoing URS + LL in our institution over a 1 year period. Patients with multiple stones, staghorn stones or incomplete stone clearance were excluded to simplify the analysis. Patient characteristics, fluoroscopy data and stone characteristics were recorded. Results: We included 302 consecutive patients in the study. The majority of stones were located in the renal calyces/pelvis (54%) with the rest located in the upper (18%), middle (13%) and lower ureter (15%). Mean stone diameter was 9.9 mm (range 4–30 mm). Mean radiation exposure time during URS + LL was 44 s (range 12–119 s) with a mean total radiation exposure of 7.5 milligray (mGy; range 1.2–29.7 mGy). Renal stones were associated with 27% higher radiation exposure compared to ureteral stones (8.3 vs. 6.7 mGy; p = 0.02). There was a positive correlation between stone diameter and radiation exposure (Spearman’s correlation coefficient ρ = 0.28; p < 0.001). Stones with diameter greater than 10 mm were associated with 37% higher radiation exposure compared to smaller stones (9.1 vs. 6.6 mGy; p < 0.001). Conclusion: There is a direct correlation between stone burden, as well as location, and radiation exposure during URS + LL. Clinicians should consider strategies to reduce total radiation exposure in recurrent stone formers at risk of high radiation exposure by limiting screening time, using pulsed rather than continuous fluoroscopy, management with primary URS + LL, or using ultrasound guidance.

Keywords:
Radiation exposure, Ureterorenoscopy, Radiation risks, Fluoroscopy
1.
Jamal JE, Armenakas NA, Sosa RE, Fracchia JA: Perioperative patient radiation exposure in the endoscopic removal of upper urinary tract calculi. Int Braz J Urol 2011; 37: 785.
2.
Sancak EB, Kılınç MF, Yücebaş SC: Evaluation with decision trees of efficacy and safety of semirigid ureteroscopy in the treatment of proximal ureteral calculi. Urol Int 2017; 99: 320–325.
3.
Yang B, Ning H, Liu Z, Zhang Y, Yu C, Zhang X, et al: Safety and efficacy of flexible ureteroscopy in combination with holmium laser lithotripsy for the treatment of bilateral upper urinary tract calculi. Urol Int 2017; 98: 418–424.
4.
Krupp N, Bowman R, Tenggardjaja C, Jellison F, Hill B, Ebrahimi K, et al: Fluoroscopic organ and tissue-specific radiation exposure by sex and body mass index during ureteroscopy. J Endourol 2010; 24: 1067–1072.
5.
Turk C, Knoll T, Petrik A, Sarica K, Seitz C, Straub M, et al: EAU guidelines on urolithiasis. Published by the European Association of Urology, 2010.
6.
De SK, Liu X, Monga M: Changing trends in the American diet and the rising prevalence of kidney stones. Urology 2014; 84: 1030–1033.
7.
Oberlin DT, Flum AS, Bachrach L, Matulewicz RS, Flury SC: Contemporary surgical trends in the management of upper tract calculi. J Urol 2015; 193: 880–884.
8.
Hsi RS, Zamora DA, Kanal KM, Harper JD: Severe obesity is associated with 3-fold higher radiation dose rate during ureteroscopy. Urology 2013; 82: 780–785.
9.
Ngo TC, Macleod LC, Rosenstein DI, Reese JH, Shinghal R: Tracking intraoperative fluoroscopy utilization reduces radiation exposure during ureteroscopy. J Endourol 2011; 25: 763–767.
10.
Mancini JG, Raymundo EM, Lipkin M, Zilberman D, Yong D, Bañez LL, et al: Factors affecting patient radiation exposure during percutaneous nephrolithotomy. J Urol 2010; 184: 2373–2377.
11.
Smith DL, Heldt JP, Richards GD, Agarwal G, Brisbane WG, Chen CJ, et al: Radiation exposure during continuous and pulsed fluoroscopy. J Endourol 2013; 27: 384–388.
12.
Elkoushy MA, Shahrour W, Andonian S: Pulsed fluoroscopy in ureteroscopy and percutaneous nephrolithotomy. Urology 2012; 79: 1230–1235.
13.
Hsi RS, Harper JD: Fluoroless ureteroscopy: zero-dose fluoroscopy during ureteroscopic treatment of urinary-tract calculi. J Endourol 2013; 27: 432–437.
14.
Olgin G, Smith D, Alsyouf M, Arenas JL, Engebretsen S, Huang G, et al: Ureteroscopy without fluoroscopy: a feasibility study and comparison with conventional ureteroscopy. J Endourol 2015; 29: 625–629.
15.
Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation and National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. 2006. http://www.amazon.com/Health-Exposure-Levels-Ionizing-Radiation/dp/030909156X (accessed July 26, 2015).
16.
Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, et al: Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169: 2078–2086.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.